Bergenbio ASA NOK0.10
Bergenbio ASA NOK0.10
3,53 %
13,50 NOK
0,46
Kurs
13,50
Hög
13,50
Förändring
3,53 %
Låg
12,76
Uppdaterad
17:37:00
Öppen
13,06
Factsheet for Bergenbio ASA NOK0.10
Company Profile
Description
BerGenBio ASA is a clinical stage oncology biotech company, which is engaged in developing therapeutics against novel drug targets that drive aggressive cancers. Its drug candidate bemcentinib (BGB324) is in clinical development as a novel treatment for a variety of cancers.
Key Stats
Website: http://www.bergenbio.com
Headquarter country: Norway
Employees: 24
Market Cap (at close 19-07-2019): NOK 789M
Fiscal Year Ends: december
Stats

Stats 2018 2017 2016 2015 2014
Price/Earnings 0,10 0,10
Forward Price/Earnings
Price/Free Cash Flow
Return on Assets -50,30 -65,20 -101,00 -66,00 -42,50
Return on Equity -55,80 -72,40 -119,10 -77,40 -47,50
Return on Invested Capital -56,80 -73,50 -119,80 -78,20 -48,40
Dividend


Dividend/Share:
Ex. Dividend Date:0001-01-01
Trailing Dividend Yield:
Payout Ratio:0,00
Date Currency Amount
Income Statement

Revenue 2018 2017 2016 2015 2014
Total Revenue 2,34 0,00 0,00 0,00 0,60
Gross Profit
Gross Margin %
Operating Expenses 2018 2017 2016 2015 2014
EBITDA -191,00 -182,00 -130,00 -72,00 -56,00
Net income -192,00 -182,00 -130,00 -72,00 -58,00
Basic Earnings Per Share -3,60 -4,01 -2,61
Operating Income -0,19 -0,18 -0,13 -0,07 -0,06
Operating Margin % -8 331,43% -9 836,79%
Cash Flow

Cash Flow 2018 2017 2016 2015 2014
Operating Cash Flow -187,00 -168,00 -124,00 -63,00 -54,00
Capital Expenditures 0,00 0,00 0,00
Free Cash Flow -187,00 -168,00 -125,00 -63,00 -54,00
Balance Sheet

Assets 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Current Assets 378,25 383,78 174,13 82,03 135,48
Long Term Assets 0,58 0,56 0,36 0,54 0,41
Total Assets 378,83 384,34 174,54 82,39 136,02
Liabilities 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Total Current Liabilities 41,55 33,99 21,27 12,07 9,95
Long Term Liabilities 0,00 5,58
Total Liabilities 21,27 17,65
Equity 2018-12-31 2017-12-31 2016-12-31 2015-12-31 2014-12-31
Retained Earnings 0,00 0,00 0,00
Treasury Stock
Total Stockholder Equity 337,28 350,35 153,27 64,75 121,61
Net Tangible Assets 337,28 350,35 153,27 64,75 121,61